Amarin Corporation PLC (AMRN) to Present at the Canaccord Genuity 33rd Annual Growth Conference
8/13/2013 9:54:43 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced that John F. Thero, Amarin's President, is scheduled to present a general company update at the Canaccord Genuity 33rd Annual Growth Conference on Thursday, August 15, 2013, at 4:00 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by